Template:PDB Gallery/7276

• 
  1bm7: HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-3-(TRIFLUOROMETHYL)PHENYL AMINO BENZOIC ACID)
• 
  1bmz: HUMAN TRANSTHYRETIN (PREALBUMIN)
• 
  1bz8: TRANSTHYRETIN (DEL VAL122)
• 
  1bzd: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
• 
  1bze: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
• 
  1dvq: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN
• 
  1dvs: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL
• 
  1dvt: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN
• 
  1dvu: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID
• 
  1dvx: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC
• 
  1dvy: CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID
• 
  1dvz: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID
• 
  1e3f: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING
• 
  1e4h: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING
• 
  1e5a: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING
• 
  1eta: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION
• 
  1etb: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION
• 
  1f41: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTION
• 
  1f86: TRANSTHYRETIN THR119MET PROTEIN STABILISATION
• 
  1fh2: TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS
• 
  1fhn: TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS
• 
  1g1o: CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55S
• 
  1gko: AN ENGINEERED TRANSTHYRETIN MONOMER THAT IS NON-AMYLOIDOGENIC - UNLESS PARTIALLY DENATURED
• 
  1ict: MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITH THYROXINE (T4)
• 
  1iii: CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT ROOM TEMPERATURE
• 
  1iik: CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT CRYO TEMPERATURE
• 
  1ijn: Crystal structure of the transthyretin mutant TTR C10A/Y114C
• 
  1qab: The structure of human retinol binding protein with its carrier protein transthyretin reveals interaction with the carboxy terminus of RBP
• 
  1qwh: a covalent dimer of transthyretin that affects the amyloid pathway
• 
  1rlb: RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN
• 
  1sok: Crystal structure of the transthyretin mutant A108Y/L110E solved in space group p21212
• 
  1soq: Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2
• 
  1tha: MECHANISM OF MOLECULAR RECOGNITION. STRUCTURAL ASPECTS OF 3,3'-DIIODO-L-THYRONINE BINDING TO HUMAN SERUM TRANSTHYRETIN
• 
  1thc: CRYSTAL STRUCTURE DETERMINATION AT 2.3A OF HUMAN TRANSTHYRETIN-3',5'-DIBROMO-2',4,4',6-TETRA-HYDROXYAURONE COMPLEX
• 
  1tlm: STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROMS OF THE HUMAN SERUM TRANSTHYRETIN-MILRINONE COMPLEX
• 
  1tsh: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
• 
  1tt6: The orthorhombic crystal structure of transthyretin in complex with diethylstilbestrol
• 
  1tta: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION
• 
  1ttb: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION
• 
  1ttc: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION
• 
  1ttr: TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT
• 
  1tyr: TRANSTHYRETIN COMPLEX WITH RETINOIC ACID
• 
  1tz8: The monoclinic crystal structure of transthyretin in complex with diethylstilbestrol
• 
  1u21: transthyretin with tethered inhibitor on one monomer.
• 
  1x7s: The X-ray crystallographic structure of the amyloidogenic variant TTR Tyr78Phe
• 
  1x7t: Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effects
• 
  1y1d: Crystal structure of transthyretin in complex with iododiflunisal
• 
  1z7j: Human transthyretin (also called prealbumin) complex with 3, 3',5,5'-tetraiodothyroacetic acid (t4ac)
• 
  1zcr: Crystal structure of human Transthyretin with bound iodide
• 
  1zd6: Crystal structure of human transthyretin with bound chloride
• 
  2b14: The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Leu 55 Pro
• 
  2b15: The crystal structure of 2,4-dinitrophenol in complex with human transthyretin
• 
  2b16: The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Tyr78Phe
• 
  2b77: Human transthyretin (TTR) complexed with Diflunisal analogues- TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID
• 
  2b9a: Human transthyretin (TTR) complexed with diflunisal analogues- TTR.3',5'-difluorobiphenyl-4-carboxylic acid
• 
  2f7i: Human transthyretin (TTR) complexed with diflunisal analogues- TTR. 2',6'-Difluorobiphenyl-4-carboxylic Acid
• 
  2f8i: Human transthyretin (TTR) complexed with Benzoxazole
• 
  2fbr: Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (4 carbon linker)
• 
  2flm: Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (6 carbon linker)
• 
  2g3x: Crystal structure of Transthyretin mutant I84S at acidic pH
• 
  2g3z: Crystal structure of Transthyretin mutant I84A at low pH
• 
  2g4e: Crystal structure of transthyretin mutant I84A at neutral pH
• 
  2g4g: Crystal structure of human transthyretin at pH 4.6
• 
  2g5u: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4,4'-dihydroxy-3,3',5,5'-tetrachlorobiphenyl
• 
  2g9k: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-2',3,3',4',5-Pentachlorobiphenyl
• 
  2gab: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-3,3',5,4'-tetrachlorobiphenyl
• 
  2h4e: Crystal structure of Cys10 sulfonated transthyretin
• 
  2noy: Crystal structure of transthyretin mutant I84S at PH 7.5
• 
  2pab: STRUCTURE OF PREALBUMIN, SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFINEMENT AT 1.8 ANGSTROMS
• 
  2rox: TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4)
• 
  2roy: TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINE
• 
  2trh: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
• 
  2try: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
• 
  5ttr: LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE